TNF‐α blockers are efficaciously utilized in the treatment of various immune‐mediated diseases, such as psoriasis, rheumatoid arthritis and, more recently, hidradenitis suppurativa (HS) 1, 2. The gene discussed is TNF; the disease is psoriasis.